Exchange: NASDAQ·Updated 11:52 AM EDT

About

GlobeImmune, Inc. is a biopharmaceutical company. It engages in the development of therapeutic products for cancer and infectious diseases based on its proprietary Tarmogen platform. The company was founded by Donald Bellgrau, Richard C. Duke, and Alex Franzusoff on February 10, 1995 and is headquartered in Louisville, CO.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of GlobeImmune Inc?
What is the 52-week high for GlobeImmune Inc?
What is GlobeImmune Inc stock price today?

Advertisement|Remove ads.